Citadel Advisors - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 39 filers reported holding NEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$11,0000.0%18,200
-12.1%
0.00%
Q3 2020$11,000
-57.7%
20,705
-39.6%
0.00%
Q1 2020$26,000
+30.0%
34,271
+116.3%
0.00%
Q2 2019$20,000
-86.8%
15,845
-72.7%
0.00%
Q1 2019$152,000
+90.0%
58,112
+20.5%
0.00%
Q4 2018$80,000
-82.1%
48,234
-47.7%
0.00%
Q3 2018$448,000
+60.6%
92,206
+107.2%
0.00%
Q2 2018$279,000
+156.0%
44,498
+314.7%
0.00%
Q4 2017$109,000
-82.3%
10,730
-84.1%
0.00%
Q3 2017$617,000
+65.0%
67,442
+158.5%
0.00%
Q4 2015$374,00026,0870.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,962,657$3,100,0002.37%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$62,0000.02%
SlateStone Wealth, LLC 62,000$39,0000.01%
Allred Capital Management, LLC 24,995$15,0000.01%
Bridge Advisory, LLC 23,564$15,0000.01%
Livingston Group Asset Management CO (operating as Southport Capital Management) 24,000$15,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$201,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 229,500$143,0000.00%
Virtu Financial LLC 41,401$26,0000.00%
TSFG, LLC 200$1,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders